IQVIA Holdings Inc. (IQV)
USD 150.92
(3.69%)
USD 150.92
(3.69%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 26.68 Billion USD | 5.3% |
| 2022 | 25.33 Billion USD | 2.62% |
| 2021 | 24.68 Billion USD | 0.51% |
| 2020 | 24.56 Billion USD | 5.65% |
| 2019 | 23.25 Billion USD | 3.11% |
| 2018 | 22.54 Billion USD | -0.85% |
| 2017 | 22.74 Billion USD | 7.23% |
| 2016 | 21.2 Billion USD | 440.15% |
| 2015 | 3.92 Billion USD | 18.77% |
| 2014 | 3.3 Billion USD | 7.79% |
| 2013 | 3.06 Billion USD | 22.71% |
| 2012 | 2.49 Billion USD | 7.59% |
| 2011 | 2.32 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 27.18 Billion USD | 2.96% |
| 2024 Q2 | 26.39 Billion USD | -0.66% |
| 2024 Q1 | 26.57 Billion USD | -0.4% |
| 2023 Q2 | 26.03 Billion USD | 1.15% |
| 2023 Q3 | 25.97 Billion USD | -0.23% |
| 2023 Q4 | 26.68 Billion USD | 2.71% |
| 2023 FY | 26.68 Billion USD | 5.3% |
| 2023 Q1 | 25.73 Billion USD | 1.59% |
| 2022 Q1 | 24.96 Billion USD | 1.13% |
| 2022 FY | 25.33 Billion USD | 2.62% |
| 2022 Q2 | 24.41 Billion USD | -2.23% |
| 2022 Q4 | 25.33 Billion USD | 4.6% |
| 2022 Q3 | 24.22 Billion USD | -0.78% |
| 2021 Q3 | 24.03 Billion USD | 0.4% |
| 2021 Q2 | 23.93 Billion USD | -2.17% |
| 2021 Q1 | 24.46 Billion USD | -0.39% |
| 2021 FY | 24.68 Billion USD | 0.51% |
| 2021 Q4 | 24.68 Billion USD | 2.73% |
| 2020 Q4 | 24.56 Billion USD | 3.05% |
| 2020 FY | 24.56 Billion USD | 5.65% |
| 2020 Q1 | 23.07 Billion USD | -0.74% |
| 2020 Q2 | 23.18 Billion USD | 0.45% |
| 2020 Q3 | 23.83 Billion USD | 2.82% |
| 2019 Q2 | 23.06 Billion USD | -0.18% |
| 2019 Q3 | 22.89 Billion USD | -0.76% |
| 2019 Q1 | 23.1 Billion USD | 2.48% |
| 2019 FY | 23.25 Billion USD | 3.11% |
| 2019 Q4 | 23.25 Billion USD | 1.57% |
| 2018 Q2 | 22.62 Billion USD | -2.62% |
| 2018 FY | 22.54 Billion USD | -0.85% |
| 2018 Q4 | 22.54 Billion USD | 0.23% |
| 2018 Q3 | 22.49 Billion USD | -0.57% |
| 2018 Q1 | 23.23 Billion USD | 2.17% |
| 2017 Q1 | 21.18 Billion USD | -0.12% |
| 2017 FY | 22.74 Billion USD | 7.23% |
| 2017 Q4 | 22.74 Billion USD | 1.32% |
| 2017 Q3 | 22.44 Billion USD | 3.04% |
| 2017 Q2 | 21.78 Billion USD | 2.83% |
| 2016 FY | 21.2 Billion USD | 440.15% |
| 2016 Q4 | 21.2 Billion USD | 413.66% |
| 2016 Q3 | 4.12 Billion USD | 4.19% |
| 2016 Q2 | 3.96 Billion USD | -0.51% |
| 2016 Q1 | 3.98 Billion USD | 1.44% |
| 2015 Q3 | 4.03 Billion USD | 20.71% |
| 2015 Q2 | 3.34 Billion USD | 3.25% |
| 2015 Q1 | 3.23 Billion USD | -2.09% |
| 2015 FY | 3.92 Billion USD | 18.77% |
| 2015 Q4 | 3.92 Billion USD | -2.66% |
| 2014 Q2 | 2.97 Billion USD | -2.72% |
| 2014 Q3 | 3.1 Billion USD | 4.3% |
| 2014 Q1 | 3.06 Billion USD | -0.16% |
| 2014 FY | 3.3 Billion USD | 7.79% |
| 2014 Q4 | 3.3 Billion USD | 6.41% |
| 2013 Q3 | 2.84 Billion USD | 7.32% |
| 2013 FY | 3.06 Billion USD | 22.71% |
| 2013 Q2 | 2.64 Billion USD | 9.13% |
| 2013 Q1 | 2.42 Billion USD | -2.9% |
| 2013 Q4 | 3.06 Billion USD | 7.91% |
| 2012 FY | 2.49 Billion USD | 7.59% |
| 2012 Q4 | 2.49 Billion USD | 0.0% |
| 2011 FY | 2.32 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Agilent Technologies, Inc. | 10.76 Billion USD | -147.896% |
| Charles River Laboratories International, Inc. | 8.19 Billion USD | -225.577% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -90.28% |
| Danaher Corporation | 84.48 Billion USD | 68.42% |
| Enzo Biochem, Inc. | 85.76 Million USD | -31009.79% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -59.527% |
| Mettler-Toledo International Inc. | 3.35 Billion USD | -695.129% |
| Qiagen N.V. | 6.11 Billion USD | -336.307% |
| Revvity, Inc. | 13.56 Billion USD | -96.695% |
| Thermo Fisher Scientific Inc. | 98.72 Billion USD | 72.975% |
| Waters Corporation | 4.62 Billion USD | -476.655% |